GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of SURPASS — 5 things I got wrong before I got it right — 40 comments in the full submission. View in context.
1.9k
c/tirzepatide·submitted 8 months ago by u/ghrp_history

SURPASS — 5 things I got wrong before I got it right

Titrationbranch of 5 comments

Confession thread, sort of. I went from 7.5mg to 2.4mg much faster than I should have because the scale had stalled and I got impatient. The stall broke about 12 weeks later, at which point I had no way of knowing whether the dose increase did anything or whether it would have broken anyway. So now I have…

Read the full submission and all 40 comments →

This branch

5 comments, started 7 months ago
u/forest_plot_fionastats41 points·7 months ago

What was the trial arm you are quoting from? SURMOUNT-1, -2, -3 are all different.

replysharereportpermalink
u/incretin_ivypharmacology17 points·7 months ago

dual agonism is GIP, do not generalise from semaglutide

replysharereportpermalink
u/ignacio_vanhecke9 points·7 months ago

Is that on Mounjaro pens or research tirzepatide?

replysharereportpermalink
u/ghrp_historyOP7 points·7 months ago

Tried both. Sema worked, tirz worked better for me, but my reflux profile was worse on tirz.

replysharereportpermalink
u/santiago_villalobos11 points·7 months ago

do not crack the pen, we have been over this

replysharereportpermalink

← back to the whole thread

About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.